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ABSTRACT
RNA G-quadruplexes (rG4s) are secondary struc-
tures in mRNAs known to influence RNA post-
transcriptional mechanisms thereby impacting neu-
rodegenerative disease and cancer. A detailed knowl-
edge of rG4–protein interactions is vital to under-
stand rG4 function. Herein, we describe a systematic
affinity proteomics approach that identified 80 high-
confidence interactors that assemble on the rG4 lo-
cated in the 5′-untranslated region (UTR) of the NRAS
oncogene. Novel rG4 interactors included DDX3X,
DDX5, DDX17, GRSF1 and NSUN5. The majority
of identified proteins contained a glycine-arginine
(GAR) domain and notably GAR-domain mutation
in DDX3X and DDX17 abrogated rG4 binding. Iden-
tification of DDX3X targets by transcriptome-wide
individual-nucleotide resolution UV-crosslinking and
affinity enrichment (iCLAE) revealed a striking as-
sociation with 5′-UTR rG4-containing transcripts
which was reduced upon GAR-domain mutation. Our
work highlights hitherto unrecognized features of
rG4 structure–protein interactions that highlight new
roles of rG4 structures in mRNA post-transcriptional
control.
INTRODUCTION
Recognition of mRNA secondary structures by RNA bind-
ing proteins (RBPs) is essential for post-transcriptional
control to influence mRNA processing, stability, transport
and translation (1,2). Watson–Crick hydrogen bonding and
non-canonical interactions are important in RNA folding,
and four-strandedG-quadruplex (G4) secondary structures
are key structural features in mRNA (3,4). G4 structures
form from guanine (G)-rich sequences in which stacks of
G-quartets are stabilized by a central metal cation (Fig-
ure 1A). Recently, high-throughput sequencing combined
with reverse transcriptase stalling at stabilized RNA G4s
(rG4) has revealed over 13 000 loci where rG4 structures
form within the human transcriptome in vitro (5,6). Evi-
dence supporting rG4 formation in cells includes detection
of rG4s in the cytoplasm by immunofluorescence using a
G4 structure-specific antibody (7,8). Notably, rG4s are en-
riched in functionally important regions, including 5′- and
3′-untranslated regions (UTRs) (5,6,9–11).
Several helicases such as DHX36 and DDX21 bind and
unwind rG4 structures with pico- or nanomolar affinities
(12–14). Another multifunctional helicase is DHX9 which
binds several nucleic acid secondary structures including
G4s but with a preference for RNA substrates (14). Thus,
cells possess specialized enzymes that recognize and resolve
rG4s which may be important for post-transcriptional pro-
cesses such as mRNA translation, transport or stability.
rG4s have been functionally implicated in several neu-
rodegenerative diseases, such as amyotrophic lateral scle-
rosis (ALS), frontotemporal dementia (FTD) and Frag-
ile X syndrome (FXS) (15,16). The underlying cause of
FXS is a CGG-rich repeat expansion in the FMR1 gene
that contributes to protein silencing due to rG4-mediated
translational inhibition (17). Likewise, ALS is defined by
a GGGGCC repeat expansion in C9orf72, which leads to
a repeat-length-dependent accumulation of aborted rG4-
containing transcripts (8). It has been proposed that rG4s
have roles in cancer development and progression as sev-
eral 5′-UTRs of oncogene mRNAs are enriched in rG4s
(5,10,11,18,19). The presence of a 5′-UTR rG4 hampers
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Figure 1. Strategy for affinity enrichment (AE) of proteins interacting with the human NRAS rG4 structure. (A) Left, schematic of a G-quadruplex
(G4) structure with three stacked G-tetrads (shaded squares) connected by intervening loops (black). Right, drawing of a G-tetrad consisting of four
Hoogsten-hydrogen bonded (red) guanines stabilized by a central metal cation (K+). (B) Left, RNA oligonucleotides used in AEs: top, the NRAS rG4
folded into a G4 structure; middle, mutated NRAS rG4(NRAS mG4) that is unable to form a G4 structure (green indicates Gs mutated to As); and
bottom a stem loop (SL, blue indicates hydrogen-bonded stem bases) from the GUS mRNA. Right, location of the rG4 sequence within the 5′-UTR of
the human NRAS transcript. (C) Workflow for AEs and liquid chromatography-tandem mass spectrometry (LC-MSMS). HeLa cell cytoplasmic extracts
were incubated with biotinylated rG4 or control oligonucleotides coupled to streptavidin beads. Affinity-purified proteins were subjected to LC-MSMS
for subsequent identification. (D) Control AEs of endogenous DHX36. HeLa cell cytoplasmic extracts were incubated with rG4, mrG4 or SL biotinylated
oligonucleotides bound to streptavidin beads or with beads alone (beads). Bound protein fractions (AEs) and flow-through (FT) were subjected to SDS-
PAGE and stained for total protein (top) or processed for western blotting with a DHX36 antibody (bottom). The presence of DHX36 protein in each lane
is presented as a percentage of the signal detected in all lanes below the western blot panel. (E) AEs and western blotting for DHX9, DHX29 and DHX30
using antibodies detecting endogenous helicases as described in (D). Input (IP) was 30 g of cytoplasmic extract. The presence of DHX9 and DHX36 in
AEs is presented as a percentage of the signal detected in all lanes below the western blot panel.
cap-dependent translation of several oncogene messages in-
cluding NRAS and BCL2 in vitro (19–21).
As rG4s frequently occur in mRNAs and have impor-
tant regulatory roles, comprehensive identification of cyto-
plasmic rG4-interacting proteins is needed to dissect rG4
function. We have therefore used an unbiased affinity pro-
teomics approach to catalog cytoplasmic interactors of the
human NRAS 5′-UTR rG4. This rG4 was selected due to
the relevance of NRAS in tumorigenesis (22). Moreover,
folding of the NRAS rG4 into a stable parallel intramolec-
ular G4 is well-characterized biophysically and this rG4
has been shown to inhibit translation in vitro (20). Herein,
we identify cytoplasmic rG4-interacting proteins that have
not previously been demonstrated to interact with an rG4
structure. Notably, over half of the rG4 interactors con-
tained a glycine-arginine-rich (GAR) domain, and we show
that this is required for the NRAS rG4-DDX3X interac-
tion. This interaction was recapitulated by transcriptome-
wide individual-nucleotide resolution UV-crosslinking and
affinity enrichment (iCLAE) in cells. Overall, our work
highlights the utility of identifying rG4-interacting proteins




Anti-MYC, Hemagglutinin tag, DHX36, DDX5, DDX17,
DHX9, DHX29 and DHX30 antibodies were purchased
from Abcam, the V5-tag antibody was obtained from
Source BioScience, DDX3X antibody was ordered from
Santa Cruz and FXR1 antibody was purchased from Cell
Signaling. RNA oligonucleotides were ordered from In-
tegrated DNA Technologies. Streptavidin magnetic beads
were obtained from Promega and Strep-Tactin magnetic
nanobeads were purchased from IBA.
Plasmids
cDNAs of rG4 interactors were purchased from vari-
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were inserted into the pDONR™221 entry vector (Ther-
moFisher) using specific primers (Supplementary Ta-
ble S4). Alternatively, RNA from HeLa cells was con-
verted into cDNA using SuperscriptIV (ThermoFischer).
Constructs that produce N-terminally or C-terminally
tagged proteins were prepared by recombination of
pDONR™221 entry clones with pcDNA™3.1/nV5-DEST
(ThermoFisher) or pCS2–6myc-GW (23). To generate sta-
ble Doxycycline-inducible cell lines expressing tagged rG4-
interactors, pDONR™221 entry clones were recombined
with the pcDNA5/FRT/TO/SH/GW destination vector
(23). RG/RGGmotif mutations were introduced by genera-
tion of overlapping fragments using corresponding primers
(Supplementary Table S4).
Cell lines
HeLa (ATCC) and Flp-In T-REx 293 cell line (Ther-
moFisher) were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Sigma) with 10% fetal bovine serum
(FBS) (Gibco) or Tetracycline-free FBS (Clontech), respec-
tively. Cells were mycoplasma tested and genotyped. Sta-
ble Flp-In T-REx 293 cell lines expressing selected Strep-
tag (ST)/HA affinity tagged rG4-interactors (23) were gen-
erated by transfecting destination vectors into cells follow-
ing the manufacturer’s instructions (ThermoFisher). Cells
were selected with Blasticidin (Gibco) and Hygromycin
D (Sigma). Single clones were tested for Doxycycline in-
ducibility.
Transfections, cell lysates, western blot and Wes Simple
Western analysis
HeLa cells were transfected at a confluency of 1 × 106
cells with 5 g of plasmid using TransIT-LT1 Transfection
Reagent (Mirus Bio LLC). After 45 h, cells were lysed us-
ing hypotonic lysis buffer with 0.5% Sodium deoxycholate,
0.5% TritonX100, 2 mM Dithiothreitol (DTT) as previ-
ously described in (24). For western blot analysis 30 g
of hypotonic extract or 25 l of 50 l affinity enrichments
(AEs) in Laemmli sample buffer (Sigma) were loaded 12%
sodium dodecyl sulphate-polyacrylamide gel electrophore-
sis (SDS-PAGE) gels (ThermoFisher) and proteins were
transferred to a nitrocellulose membrane using the iblot2
system (ThermoFisher). Membranes were blocked with
Odyssey Blocking Buffer (LI-COR) and incubated with
the first antibody followed by a second, fluorophore con-
jugated antibody (LI-COR). Fluorescent images were es-
tablished using the Odyssey CLx (LI-COR) and quantifica-
tion of bands was performed with Fiji image analysis soft-
ware. Briefly, affinity enriched protein bands were quanti-
fied by marking all bands individually with rectangular sec-
tions in the gray scale image. The Fiji software then plots
peaks representing the intensity of the band in the selected
areas. Each peak was expressed as percentage of the to-
tal size of all selected bands. Capillary electrophoresis in a
Wes SimpleWestern System (ProteinSimple) was performed
as previously described by the manufacturer (Proteinsim-
ple (https://proteinsimple.com)). The Wes immunoassay is
a capillary-based system where samples are loaded into the
capillary automatically and separated by size as they mi-
grate through a stacking and separation matrix. The sepa-
rated proteins are then immobilized to the capillary wall via
proprietary, photoactivated capture chemistry. Target pro-
teins are identified using a primary antibody and immuno-
probed using a horseradish peroxidase (HRP) conjugated
secondary antibody and a chemiluminescent substrate. The
resulting chemiluminescent signal is detected and quanti-
fied. Wes analysis was performed with 1 or 5 g of hypo-
tonic extract or 2.4 l of 50 l AEs in Laemmli sample
buffer. Each western blot or ‘Wes’ Simple Western experi-
ment is a representative of three independent experiments.
AEs and liquid chromatography-tandem mass spectrometry
(LC-MSMS)
AEs were performed as previously described with minor al-
terations (25). Prior to AEs, 10 M biotinylated oligonu-
cleotides were folded in 1 x phosphate-buffered saline sup-
plemented with 2M KCl by boiling for 5 min followed by
cooling to room temperature. Roughly, 1000g of cytoplas-
mic cell lysate were used for AEs combined with 50 l of
slurry streptavidinmagnetic beads (Promega) that were pre-
viously bound to folded, biotinylated oligonucleotides. AEs
were performed at 4◦C for 3 h in RNA-pull-down buffer
(20 mM Hepes, pH 8, 100 mM NaCl, 20% v/v glycerol,
0.2 mM ethylenediaminetetraacetic acid (EDTA), 1 mM
DTT, 0.01% Nonidet-P40, 50 g/mL yeast tRNA (Am-
bion), 160 U/ml RNasin). Magnetic beads were washed
three times with RNA-wash buffer (20 mM Hepes, pH 8,
100 mM NaCl, 20% v/v glycerol, 0.2 mM EDTA, 1 mM
DTT, 0.01% Nonidet-P40). Two biological replicates were
analyzed by LC-MSMS as previously described (26) after
on-bead trypsin digestion of affinity captured proteins. Raw
data were processed using Proteome Discoverer (v1.4) and
Mascot and/or SEQUEST as search engines.
iCLAE
Procedures were performed as previously described (27)
with the following alterations. Two 10 cm plates of Flp-
In T-REx 293 cells expressing wild-type (WT) or four 10-
cm plates for RG mutant DDX3X were seeded at a density
of 5 × 106 and protein production was induced over night
with 0.01g/mlDoxycycline. RBP–RNA interactions were
stabilized by UV crosslinking (254 nm, 200 mJ/cm2), fol-
lowed by lysis in hypotonic lysis buffer. Cytoplasmic lysates
were replenished to a final concentration of 50 mM Tris–
HCl (pH 7.4) 100 mM NaCl and 0.1% SDS. Subsequently,
RNAse/DNAase digestionwas performed as previously de-
scribed (27). AEs utilizing the Strep-tag on DDX3X and
RG mutant DDX3X were performed by incubating lysates
with Strep-Tactin magnetic beads for 3 h at 4◦C. Reverse
transcription (RT) was performed in G4 optimized lithium
RT buffer (5).
RNA-seqencing (RNA-seq)
Cells were grown in DMEM 10% FBS to 70% confluency.
Protein expression of DDX3XWT and RGmutant was in-
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ing TRI® reagent (Sigma-Aldrich) according to manufac-
turer’s instructions. RNA-seq libraries were generated using
the Illumina Truseq Stranded total RNA kit (Illumina, cat
#RS-122–2301) as per the manufacturer’s instructions and
sequenced using the Illumina NextSeq 500 kit.
Bioinformatic analysis of AE-LC-MSMS data
Significance analysis of NRAS rG4 interactors was per-
formed by using the edgeR package in RStudio (http://
www.rstudio.org/): peptide counts from the AE-LC-MSMS
data were fitted with the generalized linear model (glm-
Fit) using library size only as normalization, and P-
values and false discovery rate (FDR) were estimated
from the differential signal analysis (glmLRT) by con-
trasting NRAS rG4 counts to the merged set of nega-
tive controls (NRAS mrG4, SL and beads-only). A list of
high-confidence interactors was created by selecting only
proteins with FDR < 0.05. To represent rG4 interac-
tors in a network, high confidence interactors were im-
ported into Cytoscape version 3.5.1 (www.cytoscape.org)
(28) and intersected with physical interactions imported
from IMEX-complying databases using PSICQUIC Uni-
versal Client app. Functional modules within the network
were identifiedwith theMCODE1.4.2 app (http://baderlab.
org/Software/MCODE) and gene ontology annotations
were added using the ClueGO 2.3.3 app (http://www.
ici.upmc.fr/cluego/cluegoDescription.shtml). Term enrich-
ment was performed by right-sided hypergeometic test with
a Benjamini–Hochberg corrected P-value.
RNA-seq and iCLAE analysis
Raw sequencing files for RNA-seq libraries were prepro-
cessed using cutadapt to remove sequencing adapters and
low quality sequencing tails (options –q 10). Trimmed files
were aligned to the human genome (GRCh37/hg19) using
tophat2 and using the UCSC gtf file provided by Illumina
iGenomes as an annotation file (http://support.illumina.
com/sequencing/sequencing software/igenome.html). Gene
counts were calculated using htseq-count and the same gtf
file. Differential expression analysis was done using the R
package edgeR. Isoform quantification was performed us-
ing the cufflinks software (https://github.com/cole-trapnell-
lab/cufflinks) and the value for the same condition (WT
DDX3X, RG-mutant DDX3X and Negative) were aver-
aged. Transcripts with average FPKM of at least 0.1 in any
condition were considered as expressed, and those map-
ping to protein coding or lncRNA from the gencode ver-
sion 19 annotation (n = 24 590) were then used to assem-
ble the expressed transcriptome fasta file for the follow-
ing iCLAE analysis. Identical reads of iCLAE-seq libraries
were removed and de-multiplexed according to their 4-nt
pattern sequence at the 5′-end of each read (e.g. N3-GGTT-
N2). Libraries were then pre-processed with cutadapt to re-
move 3′ sequencing adapters and low quality sequencing
tails. Highly repetitive reads, i.e. those having at least 10
equal nucleotides (e.g. A(58), T{10,n}, etc.), were removed
and aligned to the hg19 version of the human genome us-
ing bwamem (http://bio-bwa.sourceforge.net/). After align-
ment, reads with mapping quality (MAPQ) < 10 were re-
moved and those aligning to the same position while also
having the same barcode were eliminated, as they con-
stitute most likely polymerase chain reaction duplicates.
Coverage files were calculated (bedtools), regions with sig-
nal above 10 read counts extracted and intervals closer
than 30 nt were merged into a single peak region. Merged
peak regions less than 30 nt in width were removed. Next,
only reads aligning with MAPQ ≥ 10 with expressed tran-
scripts (bwa-hg19 aligned bam files) were further mapped
to the expressed transcriptome RSEM (https://github.com/
deweylab/RSEM). Coverage transcript files were calculated
and normalized for the total estimated count in each iCLAE
library, and peaks were called. One hundred base pairs
flanking the middle of a peak were considered as binding
regions of peaks below 100 nt and sequences from these re-
gions were extracted with bedtools. UTRs and coding se-
quence (CDS) analyses was performed by considering the
same gencode version 19 annotation file as described above
(https://www.gencodegenes.org/releases/19.html). Fold en-
richment analysis was performed by randomly shuffling of
peaks throughout expressed transcripts (bedtools shuffle).
To describe the overlap with published datasets fold enrich-
ment was calculated similarly. G4 motif analysis was per-
formed by considering the following regular expression G2+
N1–12 G2+ N1–12 G2+ N1–12 G2+, summarized as (G2-L12)4.
RESULTS
Identification of cytoplasmic NRAS rG4-interacting proteins
Weapplied an unbiased proteomics approach to identify cy-
tosolic proteins that interact with the NRAS 5′-UTR rG4
structure. Biotinylated oligonucleotides containing the rG4
sequence found in the 5′-UTR of NRAS were folded into a
rG4 structure (see ‘Materials andMethods’ section). Folded
rG4 and control oligonucleotides (Figure 1B) were immo-
bilized on streptavidin beads and used as baits for affinity
enrichments (AEs) of proteins from HeLa cell cytosolic ex-
tracts (Figure 1C) (25). To critically evaluate specific rG4
interactors, aG-to-AmutatedNRAS sequence (mrG4) that
is unable to fold in to a G4, a stem-loop-forming sequence
(SL), and empty beads (beads i.e. no oligonucleotide) were
used in independent AEs (Figure 1B). The integrity of rG4
formation and the failure to form a G4 structure in the mu-
tated control was confirmed in vitro using circular dichro-
ism spectroscopy (CD) and UV thermal melting analysis
(Supplementary Figure S1). Using an anti-DHX36 anti-
body, we confirmed strong enrichment of DHX36, a well-
known rG4 interactor, in the NRAS rG4 (90%) AEs com-
pared to the mrG4 (3.3%), SL (3.6%) and bead (2.3%) con-
trols, which validated our approach (Figure 1D). Intrigu-
ingly, assessment of selected DHX helicase family members
using antibodies recognizing endogenous proteins showed
that theNRAS rG4 interacted selectively withDHX9 (94%)
compared to controls (mrG4 3.4%, SL 0%, beads 1.5%) but
did not enrich for DHX30 or DHX29 (Figure 1E). These
data suggest high specificity and selectivity of our assay.
Next, proteins bound to the rG4 oligonucleotides and
control samples were subjected to on-bead tryptic diges-
tion followed by LC-MSMS (26). We chose this qualita-
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effectiveness and the relatively low requirement for bioin-
formatic analysis as compared to stable isotope labeling
by amino acids in cell culture (SILAC) (29). Two biologi-
cal replicates showed high reproducibility, as judged by dot
plots comparing unique peptide counts (UPCs) from each
replicate (r= 0.67 - 0.85) (Supplementary Figure S2). Over-
all, 711 proteins interacted with RNA (rG4, mrG4 or SL
but not beads). NRAS rG4-specific interactors were then
identified by comparing UPCs of rG4 interactors to con-
trols (CTRs: mrG4, SL and beads) using a linear fit model
(Figure 2A and B; Supplementary Table S1). These were
then ranked according to their false discovery rate (FDR)
(significant FDR< 0.05, column ‘FDR.G4 vs CTRs’ Sup-
plementary Table S1) which revealed 80 significant rG4 in-
teractors. A more refined list was curated by only consid-
ering proteins with 6 or more UPCs, resulting in 35 rG4-
specific proteins (column ‘G4.av ≥ 6’ Supplementary Ta-
ble S2). These strict selection criteria identified novel and
previously characterized rG4-interacting proteins, includ-
ing DHX36 (ranked 5) and DHX9 (ranked 31).
Functional relationships within the primary list of 80
NRAS rG4 interactors were determined using Cytoscape,
which generates a network of physical relationships (edges)
between the interactors (nodes) (28,30) and their probabil-
ity of interaction with the NRAS rG4 bait (Supplementary
Tables S1 and 2; Figure 2C). Known and predicted candi-
date RBPs (green and orange diamonds, respectively, Fig-
ure 2C) were then overlaid on to this network (31,32). No-
tably, the majority of NRAS rG4 interactors have previ-
ously been annotated as RBPs (48 proteins, 60%). How-
ever, 32 proteins (orange circles) were not known as RBPs.
Highly connected nodes were identified computationally
(33), which revealed several interconnected complexes such
as the HRNPH1/DDX5/DDX17 complex previously de-
scribed to influence rG4-dependent splicing (34). Another
complex not previously linked to rG4-mediated mecha-
nisms was the eIF4E2/GIGYF1/GIGYF2 complex, which
has a role in the negative regulation of translation initia-
tion during development (35). Gene Ontology enrichment
analysis was then performed to test which functional cate-
gories were over-represented in the rG4 interactor dataset
(36) (Figure 2D and Supplementary Figure S3). Of 80
high-confidence rG4 binders, 55 were assigned to specific
terms/pathways, including splicing (19 proteins), purine
NTP-dependent helicase activity (10 proteins), regulation
of splicing (6 proteins) and RNA biogenesis (polyadeny-
lation, cleavage and 3′-end processing, 7 proteins). Strik-
ingly, rRNA base methylation was the most significantly
enriched term, with NSUN5, an rRNA methylase (37), be-
ing ranked the fourth most significant interactor (Supple-
mentary Table S2). Overall, our approach has identified new
rG4-interacting proteins giving insights into previously un-
known and unexpected functions for rG4s and their binding
partners.
Validation of identified NRAS rG4 interactors
To validate the rG4-binding proteins identified, selected
proteins were epitope-tagged with either N-terminal V5
(NV5) or C-terminal MYC (CMYC) and AEs were per-
formed with rG4 or control baits followed by Wes Sim-
ple Western analysis to evaluate rG4–protein interactions.
Candidates were chosen based on the ranking of the
proteins (Supplementary Table S2) and potential links
to G4-mediated control mechanisms. Hence, cytoplasmic
actin/tubulin transport affiliated proteins (kinesins KIF22
and KIF23), or kinases (MARK3, CDK12), or NFX1,
which is a general nuclear-cytoplasmic RNA export fac-
tor (38), were excluded for this study. For similar rea-
sons, the GIGYF1/GIGYF2/eIF4E2 complex, which in-
hibits translation initiation, was not studied (35). We fo-
cused on DDX17 and DDX5, each of which has a re-
ported G4-relevant role in splicing (34), but their role in
post-transcriptional control is not well explored. DDX3X
is a DEAD box helicase related to DDX17 and DDX5
but there is no previous report of a DDX3X–rG4 interac-
tion. Further candidates selected for validation were FXR1
and FXR2, which are homologs of the fragile X men-
tal retardation protein (FMRP) that is known to bind to
G4s (39). While the expression of several tagged proteins
could be confirmed (Figure 3A), RBM6 (Rank 1) and
PRRC2B (Rank 2) could not be transiently expressed (data
not shown). Endogenous DHX36 binding to the NRAS
rG4 but not to control RNAs was used as a positive control
(Figure 3B and C). As endogenous DHX29 did not interact
with any baits (Figure 1E), tagged DHX29 was used as a
negative control and showed no binding confirming that the
epitope tag does not independently interact with oligonu-
cleotide baits (Figure 3B).
Using this approach, we confirmedGRSF1, NSUN5 and
FXR2 as rG4-binding proteins that had no or minimal
binding to mrG4, SL or B controls (Figure 3C). Likewise,
we determined the DEAD box helicase DDX3X as a novel
rG4 interactor and that the DDX5 and DDX17 helicases
were also specifically enriched by the NRAS rG4. Previ-
ously, eIF4AI, another DEAD box RNA helicase pivotal
for translational initiation, was shown to unwind rG4 struc-
tures (19). In our AE-LC-MSMS experiments eIF4AI was
not a significant interactor (ranked position 1102, Supple-
mentary Table S1) and tagged eIF4AI expression did not re-
veal any interaction with the NRAS rG4 bait (Figure 3B).
eIF4AIII, another helicase closely related to eIF4AI (40),
but not known to interact with rG4s, also showed lower
binding toNRAS rG4 as compared toDHX36 (Figure 3B),
despite being ranked 32 in the high confidence interactors.
Together, our experiments confirmed specific interaction of
the NRAS rG4 with several identified high-confidence in-
teractors.
Differential selectivity for rG4 structures by NRAS rG4-
binding proteins
RBPs can bind several mRNA targets and, in some cases,
can interact with DNA through cytoplasmic-nuclear shut-
tling to execute different functions (1,41). We therefore
explored the binding selectivity of identified NRAS rG4-
interacting proteins for the 5′-UTR rG4 (BCL2) and for
DNA G4 versions of the NRAS and BCL2 sequences. The
folding of oligonucleotides into G4s was confirmed by CD
spectroscopy and UV thermal melting spectroscopy (Sup-
plementary Figure S1). Proteins were affinity-enriched with
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Figure 2. High-confidence proteins interacting with the NRAS rG4 structure. (A) Scatter plot of average unique peptide counts (UPCs) (left), and average
spectral counts (right), comparingNRAS rG4AEs relative to controls (mrG4, SL and beads) (Supplementary Figure S2 and Table S2). Each dot represents
one protein. The X-axis shows the average of peptide (or spectral) counts for mrG4, SL and beads combined (six replicates). The Y-axis represents the
average of peptide (or spectral) counts for NRAs rG4 (two replicates). Proteins in red are significantly enriched. (B) Overview of filtering parameters
to identify high-confidence interactors; false discovery rate (FDR) (C) Cytoscape analysis of 80 high-confidence NRAS rG4 interacting proteins. Green
diamonds represent previously identified mRNA binding proteins, dark orange diamonds represent candidate mRNA binding proteins and light orange
circles represent novel rG4 interactors not previously known as a mRNA-binding proteins. The width of orange lines (edges) describes the probability
(‘FDR.G4 vs rest’ Supplementary Table S2, sheet ‘FDR> 0.05’) of interaction with the NRAS rG4-binding proteins. Blue edges between high confidence
interactors are previously published interactions. (D) Gene ontology analysis pie chart of significantly enriched functional groups for identified high-
confidence rG4 interactors. Figures in brackets are the number of proteins in each group.
NRAS or BCL2 G4 structures (Figure 4A). Endogenous
DHX36 served as a positive control. DHX36 exhibited an
apparent preference for NRAS over BCL2 oligos. When
RNA or DNA forms of NRAS or BCL2 were compared,
RNA oligos appeared to preferentially bind DHX36 (Fig-
ure 4B). Each of the affinity-tagged NRAS rG4-interacting
proteins, GRSF1, NSUN5, DDX3X, DDX17 or FXR2
showed an individual qualitative preference for different
G4s (Figure 4B), with a general preference for rG4s over
DNAG4s and for NRAS over BCL2. Notably, NSUN5 ap-
peared to show significant selectivity for the NRAS rG4.
We next evaluated endogenous rG4–protein interac-
tions by immuno-detection using specific antibodies (Fig-
ure 4C). The binding specificity of tagged DDX3X (Fig-
ure 4B) was accurately recapitulated by the endogenous
DDX3X protein (Figure 4C). Results for endogenous and
epitope-tagged DDX17 also suggest an interaction with
rG4 structures. Our results show that endogenous DHX9,
a known rG4 binder (13), preferentially interacted with the
NRAS/BCL2 rG4s when compared to DNA G4s. Com-
parable to its tagged homolog FXR2, endogenous FXR1
was also seen to associate with rG4s but not DNA G4s,
while GRSF1 binds all G4s tested. Endogenous DHX9 and
DHX30 showed no evidence of G4 interaction (Figure 4C).
Together, these data indicate that identified rG4 interactors
have a preference for selected rG4s over the corresponding
DNA versions.
Glycine-arginine domains are enriched in NRAS rG4 inter-
actors
GAR domains are comprised of RGG and/or RG repeats
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Figure 3. Validation of novel NRAS rG4 high-confidence interactors. (A) Expression of epitope-tagged rG4-interacting proteins in HeLa cells followed by
Wes Simple Western analysis for indicated tags, NV5 (N-terminal tag) or CMYC (C-terminal tag). A total of 1 g of cytoplasmic lysate was loaded. (B and
C) AEs for indicated proteins from cytoplasmic HeLa cell extract as per Figure 1 using rG4, mrG4 and SL oligonucleotides or bead only baits followed
by Wes Simple Western analysis detecting the epitope tag. As positive control AEs of endogenous DHX36 is shown below each blot. Numbers on top of
indicated proteins show ranking of the respective protein according to Supplementary Table S1 (FDR< 0.05; 80 interacting proteins) or in bold according
to Supplementary Table S2 (FDR < 0.05 UPC ≥ 6; 35 interacting proteins). A total of 5 g of cytoplasmic lysate was loaded.
fore, we calculated the presence of di/tri-RGG and di/tri-
RG motifs in 35 most significant NRAS G4 interactors
described above. In total, 55.8% of the 35 NRAS rG4-
binding proteins contained di-RGG/tri-RG (38.2%) or di-
RG (17.7%) domains. This contrasts with only 5.2% di-
RGG/tri-RG or 8.0% di-RG motifs detected in the en-
tirety of proteins identified by AE-LC-MSMS (NRAS rG4,
mrG4, SL and beads) (Figure 5A and B).
Next, we explored whether binding of selected proteins,
DDX3X, DDX5 and DDX17, (Figure 5C) to the NRAS
rG4 structure is dependent on GAR domains by mutating
certain arginines in the RG/RGG domain to alanine (Sup-
plementary Tables S1, 3 and 4). Affinity-tagged versions of
WT and mutant proteins (mRG) were expressed in HeLa
cells (Figure 5D) and the binding to rG4 oligonucleotides
and controls tested (Figure 5E). RG/RGG domain muta-
tion of DDX3X and DDX17 substantially abrogated bind-
ing to the NRAS rG4 bait (Figure 5E). By contrast, muta-
tion of the DDX5 GAR domain did not disrupt rG4 bind-
ing indicating that another domain in the protein must fa-
cilitate binding.
The GAR domain in DDX3X mediates interaction with rG4-
containing mRNAs in cells
Our AE-LC-MSMS experiments revealed DDX3X as a
new rG4-interacting protein. DDX3X is implicated in sev-
eral aspects of RNA biology and mutations in DDX3X
are linked to tumorigenesis, especially medulloblastoma
(43,44). Thus, we aimed to identify whether DDX3X in-
teracts specifically with endogenous transcripts contain-
ing rG4s. Importantly, in contrast to earlier individual-
nucleotide resolution UV-crosslinking and immunoprecipi-
tation (iCLIP) experiments (45,46), our approachwas based
on the antibody free Strep-tag––Streptactin system for AEs
(see ‘Materials and Methods’ section). Furthermore, the
method was adapted to enhance the recovery of rG4 tar-
gets by comparing WT DDX3X with the rG4-binding im-
paired RG-mutant together with protocol enhancements
to recover G-rich rG4 motifs (see ‘Materials and Meth-
ods’ section). Hence, we performed individual-nucleotide
resolution UV-crosslinking affinity enrichments (iCLAE)
using HEK293 cells expressing Strep-tag/haemaglutinin
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NRAS rG4    UGUGGGAGGGGCGGGUCUGGGUGC
NRAS dG4    TGTGGGAGGGGCGGGTCTGGGTGC
NRAS mG4   UGUAGAAAGAGCAGAUCUAGAUGC
BCL2 rG4      CUCGGGGGCCGUGGGGUGGGAGCUGGGGCGA

















































































































































Figure 4. Differential G4 selectivity of selected high-confidence rG4 interactors. (A) Sequences for RNA (rG4/mG4) or DNA (dG4) G4 oligonucleotides.
Red or purple letters indicate tetrad Gs. Shown in green are G to A mutations in the NRAS rG4 sequence which prevent G4 folding. (B) AEs and Wes
Simple Western analysis for expressed-tagged proteins were performed as described in Figures 1 and 3 with endogenous DHX36 used as a positive control.
A total of 1 g of cytoplasmic cell lysates (L) loaded in GRSF1, NSUN5 and DDX3X panels while 5 g were loaded in the DDX17 and FXR2 panels.
(C) as (B) but using antibodies against selected endogenous proteins.
endogenous levels (Figure 6A) (27,47). Next, cells were
UV irradiated to cross-link RNAs to WT or RG-mutant
DDX3X followed by isolation of cytoplasmic RNA–
protein complexes. After RNAse treatment and RNA end-
labeling, ST/HA-tag AEs recovered similar amounts of
WT and RG-mutant DDX3X protein (Figure 6B), but less
RNA was obtained from the RG-mutant compared to WT
DDX3X (Figure 6C). iCLAE libraries were prepared using
a lithium buffer for reverse transcription to prevent poly-
merase stalling atG-rich regions (5). To improve recovery of
the reduced RNA binding by the RG-mutant, an increased
number of cells was used as startingmaterial in this case. No
library was amplified from the ‘beads only’ control (Sup-
plementary Figure S4). iCLAE and total RNA sequencing
reads were aligned to the human genome (hg19) and peaks
were called for regions with ≥ 10 reads with a maximum
allowed gap of 30 nt (see ‘Materials and Methods’ section).
Overall, 5443 WT DDX3X peaks were identified in two
out of three biological replicates, which corresponds with
previously published iCLIP datasets (Supplementary Fig-
ure S5A–C). The majority of peaks (4457, 82%,) aligned
within coding transcripts, 12% (660) to non-coding regions
and 6% (328) to intergenic regions (Figure 6D). Most non-
coding peaks (55%) were annotated as pseudogenes includ-
ing long non-coding (23%) and antisense RNAs (7%), while
the remainder mapped to rRNA, snRNA and other miscel-
laneous RNAs (Figure 6E). To rule out any bias from non-
specific binding due to transcript abundance, we evaluated
the correlation between gene expression levels and iCLAE
signal forWTDDX3Xprotein (Supplementary Figure S6A
and B). There was little correlation (r= 0.29) between tran-
script levels and WT DDX3X binding. As the DDX3X-
specific iCLAE signal was primarily found in coding tran-
scripts, we re-aligned the reads to the human coding tran-
scriptome. This revealed that mutation of the GAR domain
significantly altered the binding properties of DDX3X re-
sulting in a reduced peak count (3446) with 48% overlap
with the WT protein. (Figure 6F, see ‘Materials and Meth-
ods’ section and Supplementary Table S5). Of the 4110
WT DDX3X-specific peaks, 1697 were located within the
5′-UTRs (∼6-fold enrichment) and 1921 in coding exons
(∼3-fold enrichment) (Figure 6G). Furthermore, an altered
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Figure 5. GAR domains are common to high-confidence rG4 interactors and are important for rG4 interactions. (A) Occurrence of tri-, diRGG/RG or
diRGmotifs in the 35 high confidenceNRAS rG4 interactors. (B) Statistical analysis of tri-, diRGG/RGor diRGmotif frequency compared to background.
‘Identified proteins’ are all AE-LC-MSMS identified proteins, proteins in ‘beads only’ condition subtracted. NRAS G4 binders represent the top 35 high
confidence rG4 interactors (FDR < 0.05 UPC ≥ 6, Supplementary Table 2). (C) Overview of DDX5, DDX3X and DDX17 showing positions of tri-,
diRGG/RG or diRG motifs and indicated domains. (D) Expression of DDX5, DDX3X and DDX17 and GAR-mutant versions (mRG) in HeLa cells
detected by Wes Simple Western analysis for the indicated epitope tag. A total 1 g of cytoplasmic cell extract was loaded. (E) AEs and Wes Simple
Western analysis for expressed, tagged proteins and their GAR-mutant counterparts were carried out as for Figures 1 and 4 with endogenous DHX36 used
as a positive control. A total of 1 g of cytoplasmic extract was loaded.
tected when WT DDX3X and the RG-mutant were com-
pared (Figure 6H).
To investigate potential binding targets, a motif analysis
was performed in which 100 nt around the center of peaks,
located within annotated transcripts, were scanned for the
presence of the (G2-L12)4 G4 motif (Figure 6I). Strikingly,
the G4 motif was found in 55% of unique WT DDX3X
peaks. Even though more cells were used to obtain a library
in the DDX3X RG-mutant condition, only 23% of peaks
contained the G4 motif (P = 3.4e-112 with the Chi-square
test for proportions; method prop.test() in the statistical
software R). The impaired rG4-binding ability of the RG-
mutant DDX3X is consistent with our AE experiments that
showed that the RG-mutant DDX3X protein is not cap-
tured by the NRAS rG4 bait (Figure 5E). MEME motive-
based sequence analysis revealed that DDX3X binding sites
that do not contain an rG4 defined by (G2-L12)4 still con-
tained G-rich sequence motifs (motif 1, 4 and 5 in Supple-
mentary Figure S7A). There is potential for these G-rich
regions to form non-canonical G-quadruplexes. Interest-
ingly, the non-rG4 binding RG-mutant shows enrichment
for A-rich motifs (motive 2 and 6, Supplementary Figure
S7A), perhaps reflecting the increased 3′-UTR binding of
the DDX3X mutant (Figure 6H).
To reveal possible biological pathways regulated by
DDX3X rG4-binding, we selected mRNAs with peaks in
the top quartile containing a G4 (G2-L12)4 motif with a
logFC > 1 when compared to the mutant DDX3X iCLAE
signal (P < 0.05). This generated a list of 104 DDX3X tar-
get mRNAs (Supplementary Table S6). When the binding
of WT and RG-mutant DDX3X to 5′-UTRs of mRNAs
of several cancer-related genes was compared, a clear re-
duction in signal could be seen in the mutant condition
(Figure 6J and Supplementary Figure S7B). Gene ontol-
ogy enrichment analysis assigned 84 transcripts to specific
terms/pathways including adenosine triphosphate mainte-
nance and mitochondrial membrane integrity terms (Sup-
plementary Figure S7C). It was evident that DDX3X binds
to several mRNAs that encode components of the oxida-
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Figure 6. DDX3XmRNAbinding is enriched at G4 sites in 5′-UTRs and depends on the presence of an intact GAR domain. (A)Western blotting showing
expression of tagged WT DDX3X and RG-mutant (mRG) DDX3X protein in FLP-In T-Rex293 cells after Doxycycline induction for 24 h. DDX3XWT
and RG-mutant DDX3X are expressed at similar levels to endogenous DDX3X, detected using an antibody against DDX3X. (B) Western blot confirming
AEs of tagged WT and RG-mutant DDX3X using anti-HA antibodies for detection. Western blotting was performed on affinity-purified material that
was used for the iCLAE procedure. (C) Autoradiograph of WT and RG-mutant DDX3X complexed with radiolabeled cellular RNA before (−) and
after RNAse (+) treatments. (D) Distribution of WT DDX3X peaks using Gencode (v19) annotation. (E) Distribution of WT DDX3X peaks within
non-coding transcripts. Other denotes rRNA, snRNA and miscellaneous RNAs. (F) Venn-diagram showing the overlap and unique peaks for WT and
RG-mutant DDX3X proteins after transcriptome alignment. (G and H) Distribution (G) and enrichment (H) of WT and RG-mutant DDX3X proteins.
Peak enrichment calculated following random shuffling of peaks in the expressed transcripts. (I) Percentage of occurrence of the G4motif (G2-L12)4 within
WT and RG-mutant DDX3X. ( J) Genome browser view of NRAS and CDK1mRNAs. iCLAE tracks show peaks ofWT or RG-mutant of DDX3X. The
CDS tract describes the open reading frame of the plotted transcript and underneath the predicted (G2-L12)4 motives within the transcripts were added.
in the regulation of energy production in the cell (Supple-
mentary Figure S7D). Overall, these findings suggest that
WTDDX3X binds a subset of mRNA targets through rG4
recognition mediated by its GAR domain and that this in-
teraction is notable for components of the oxidative phos-
phorylation machinery.
DISCUSSION
A greater understanding of the roles of rG4 structures
in mRNA post-transcriptional control will be achieved
through a comprehensive knowledge of associated proteins.
Over 1500 human RBPs have been cataloged (31,48), with
most having no assigned role. Affinity selection has defined
sequence motifs for only ∼200 RBPs (49), so it remains a
critical question whether RNA secondary structure or the
sequence per se, is pivotal for RNA–RBP interaction. As
a step towards this, we have developed an unbiased AE-
LC-MSMS approach to identify cytoplasmic RBPs that in-
teract with the NRAS 5′-UTR rG4 structure. The largest
category of rG4 interactors consisted of proteins involved
in RNA splicing and processing, followed by proteins in-
volved in translation. Curiously, rRNA base methylation
was revealed as a significant term (P-value< 0.0005), which
may be important since FMRP binding sites are enriched in
6mA-methylation at rG4 motifs (50). Another example of
a regulatory RBP–rG4 epigenetic interaction is seen with
the polycomb repressive complex (PRC2), which recognizes
rG4s in histone-associated RNAs to promote epigenetic si-
lencing (51).
It is noteworthy that we identified several helicases as
significant rG4 interactors. This supports the view that
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ing rG4 structures. It has been suggested that in cells rG4s
are globally unfolded, which is mediated by rG4 interact-
ing proteins (6). However, these conclusions are drawn from
transcriptome-wide averaging and may obscure the dynam-
ics of rG4 formation in individual transcripts. Within the
helicases, eIFA4I was not observed as a specific rG4 binder
(Figure 3B and Supplementary Table S1). This contrasts
with earlier work combining ribosome foot-printing with
eIF4AI inhibition which suggested a link between rG4s and
eIF4AI (19). A possible explanation is that rG4 association
with eIF4AI can only be detected under conditions when
eIF4AI is hampered by small molecules and is part of the
translation initiation complex eIF4F (19,52).
GAR domains are commonly found in RBPs including
several known rG4-interacting proteins (39,53–55). Here,
we have extended the number of rG4 interactors that con-
tain a GAR domain and we have confirmed that rG4-
binding was abrogated by mutation of this domain for
DDX3X and DDX17. Our work and the work of others
(56) has revealed several rG4-interacting proteins, includ-
ing GRSF1 and NSUN5, that do not possess a GAR do-
main. This might point to the existence of two classes of
rG4-interacting proteins, one dependent on the presence of
the GAR domain and another class possessing alternative
RNA-binding modes specialized for rG4 recognition.
The main focus of our study was identification of rG4-
dependent mRNA binders in the cytoplasm. Hence, cyto-
plasmic extracts rather than total cell extracts were used. In-
deed, we could determine several new rG4-binding proteins
but also proteins that had been detected in rG4-dependent
AEs from total cell extracts, such as GRSF1 and NSUN5
(56). While GRSF1 is a protein targeted to mitochondria,
NSUN5 is considered a nuclear protein. Our targeted ap-
proach, with focus on cytoplasmic events, now suggests
NSUN5 as a potential shuttling protein that might have
roles inmethylation ofmRNAs in the cytoplasm. For future
experiments, it is important to study localization of rG4-
binding proteins in regards to their molecular function.
Unraveling the function of rG4 interactors also requires
identification of their mRNA targets. We were particularly
interested in rG4 structures as recognition elements for
rG4s-binding proteins. To address this, we compared WT
DDX3X to RG-mutated DDX3X iCLAE data. The anal-
ysis of DDX3X iCLAE experiment uses stringent log-fold
change cut-off of one to generate Supplementary Table S6
which shows for the first time that DDX3X, an impor-
tant cancer-related helicase, has a set of RNA targets that
require an rG4 structure for recognition. However, using
these stringent restrictions might prevent detection of other
mRNA targets. For instance, the iCLAE experiment detects
peaks over the NRAS 5′-UTR as shown in Figure 6J and
listed in Supplementary Table S5 and a decrease in DDX3X
binding uponmutation of theGARdomain is evident. Still,
this decrease does not meet the stringent cut off log-fold
change cut-off of one (Log2 fold for NRAS - 0.65).
It is noteworthy that we uncovered a cluster of DDX3X
targets that encode proteins involved in the oxidative phos-
phorylation chain. Indeed, dysregulation of the synthesis
of oxidative phosphorylation components has severe con-
sequences and is linked to several diseases, including Hunt-
ington’s, Alzheimer’s, Parkinson’s disease (57) and cancer
(58).
In summary, we have identified new cytoplasmic RBPs
that interact with the rG4 secondary structure. The major-
ity of rG4 binders contain GAR domains and mutation
of this domain in the clinically important rG4-interacting
protein DDX3X hampered the interaction in vitro and in
cells. Moreover, we discovered that DDX3X mRNA tar-
gets are significantly enriched in rG4s with most of the top
104mRNAs encoding for essential components of themito-
chondrial oxidative phosphorylation chain. The discovery
of rG4-interacting proteins will enable future mechanistic
studies of rG4 dynamics and function in the cell.
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